{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:30:40Z","timestamp":1789939840520,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"crossref","award":["H2022201035"],"award-info":[{"award-number":["H2022201035"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"crossref","award":["H2021201060"],"award-info":[{"award-number":["H2021201060"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"crossref","award":["H2024201029"],"award-info":[{"award-number":["H2024201029"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52203171"],"award-info":[{"award-number":["52203171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Foundation of Hebei Educational Committee","award":["BJK2024192"],"award-info":[{"award-number":["BJK2024192"]}]},{"name":"Advanced Talents Incubation Program of Hebei University","award":["521100223231"],"award-info":[{"award-number":["521100223231"]}]},{"name":"Advanced Talents Incubation Program of Hebei University","award":["521100223229"],"award-info":[{"award-number":["521100223229"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Osteoporosis (OP) is a common systemic metabolic bone disease characterized by the decrease in bone mass and hyperactivity of osteoclasts. ACT001 is approved as an orphan drug by FDA and has shown multiple protective effects against tissue injury. However, its role in prevention of osteoclast differentiation and the underlying mechanisms have not been elucidated. Herein, we show that ACT001 inhibited RANKL-induced osteoclast differentiation and F-actin ring formation through suppressing the expression of Nfatc1, TRAP, Ctsk, Dc-stamp without obvious cytotoxicity in vitro. ACT001 restrained the phosphorylation of NF-\u03baB and the activation of NLRP3 inflammasome, thereby decreased the expression of pyroptosis-related protein. (GSDMD, caspase-1, IL-1\u03b2, IL-18). Consistent with ACT001, the NLRP3 inflammasome inhibitor MCC950 treatment also suppressed the osteoclastogenesis through inhibiting the transcriptional activation of Nfatc1. Furthermore, ACT001 protected ovariectomy-induced bone loss in mice, reduced the number of osteoclasts, downregulated the expression of NLRP3 and IL-1\u03b2. These data indicate that ACT001 can reduce RANKL-induced osteoclast differentiation through suppressing the NF-\u03baB\/NLRP3 pathway, and attenuate the bone loss induced by estrogen-deficiency, suggesting its therapeutic potential for bone homeostasis maintenance and osteoporosis treatment.<\/jats:p>","DOI":"10.1186\/s10020-025-01189-3","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T20:26:05Z","timestamp":1744057565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["ACT001 improves OVX-induced osteoporosis by suppressing the NF-\u03baB\/NLRP3 signaling pathway"],"prefix":"10.1186","volume":"31","author":[{"given":"Yuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Zhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Na","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Shuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"1189_CR7","doi-asserted-by":"crossref","unstructured":"Adejuyigbe B, Kallini J, Chiou D, Kallini JR. (2023) Osteoporosis: molecular pathology, diagnostics, and therapeutics. Int J Mol Sci 24.","DOI":"10.3390\/ijms241914583"},{"key":"1189_CR34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ni.3772","volume":"18","author":"IS Afonina","year":"2017","unstructured":"Afonina IS, Zhong Z, Karin M, Beyaert R. Limiting inflammation-the negative regulation of NF-kappaB and the NLRP3 inflammasome. Nat Immunol. 2017;18:861\u20139.","journal-title":"Nat Immunol"},{"key":"1189_CR23","doi-asserted-by":"crossref","unstructured":"Aibar-Almazan A et al. (2022) Current status of the diagnosis and management of osteoporosis. Int J Mol Sci 23.","DOI":"10.3390\/ijms23169465"},{"key":"1189_CR33","doi-asserted-by":"crossref","first-page":"12515","DOI":"10.1096\/fj.201802805RR","volume":"33","author":"Y An","year":"2019","unstructured":"An Y, et al. Activation of ROS\/MAPKs\/NF-kappaB\/NLRP3 and Inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB J. 2019;33:12515\u201327.","journal-title":"FASEB J"},{"key":"1189_CR26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s40520-021-01817-y","volume":"33","author":"J Barnsley","year":"2021","unstructured":"Barnsley J, et al. Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res. 2021;33:759\u201373.","journal-title":"Aging Clin Exp Res"},{"key":"1189_CR18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12964-022-00862-y","volume":"20","author":"L Cai","year":"2022","unstructured":"Cai L, et al. ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT\/NFkappaB\/NLRP3 pathway. Cell Commun Signal. 2022;20:56.","journal-title":"Cell Commun Signal"},{"key":"1189_CR37","doi-asserted-by":"crossref","first-page":"112382","DOI":"10.1016\/j.mce.2024.112382","volume":"594","author":"G Cai","year":"2024","unstructured":"Cai G, et al. NLRP3 Blockade by MCC950 suppressed osteoclastogenesis via NF-kappaB\/c-Fos\/NFATc1 signal pathway and alleviated bone loss in diabetes mellitus. Mol Cell Endocrinol. 2024;594:112382.","journal-title":"Mol Cell Endocrinol"},{"key":"1189_CR2","doi-asserted-by":"crossref","unstructured":"Eastell R, et al. (2016) Postmenopausal osteoporosis. Nat Rev Dis Primers 2: 16069.","DOI":"10.1038\/nrdp.2016.69"},{"key":"1189_CR43","doi-asserted-by":"crossref","first-page":"10732","DOI":"10.18632\/aging.205111","volume":"15","author":"Z Gan","year":"2023","unstructured":"Gan Z, et al. Micheliolide prevents Estrogen deficiency-induced bone loss via inhibiting osteoclast bone resorption. Aging. 2023;15:10732\u201345.","journal-title":"Aging"},{"key":"1189_CR5","doi-asserted-by":"crossref","unstructured":"Gao Y, Patil S, Jia J. (2021) The development of molecular biology of osteoporosis. Int J Mol Sci 22.","DOI":"10.3390\/ijms22158182"},{"key":"1189_CR15","doi-asserted-by":"crossref","first-page":"108944","DOI":"10.1016\/j.intimp.2022.108944","volume":"110","author":"H Guo","year":"2022","unstructured":"Guo H, et al. ACT001 suppressing M1 polarization against inflammation via NF-kappaB and STAT1 signaling pathways alleviates acute lung injury in mice. Int Immunopharmacol. 2022a;110:108944.","journal-title":"Int Immunopharmacol"},{"key":"1189_CR17","doi-asserted-by":"crossref","first-page":"115037","DOI":"10.1016\/j.bcp.2022.115037","volume":"200","author":"J Guo","year":"2022","unstructured":"Guo J, et al. A rational foundation for micheliolide-based combination strategy by targeting redox and metabolic circuit in cancer cells. Biochem Pharmacol. 2022b;200:115037.","journal-title":"Biochem Pharmacol"},{"key":"1189_CR27","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00198-023-06789-5","volume":"34","author":"E Hesari","year":"2023","unstructured":"Hesari E, et al. Osteoporosis medication adherence tools: a systematic review. Osteoporos Int. 2023;34:1535\u201348.","journal-title":"Osteoporos Int"},{"key":"1189_CR22","doi-asserted-by":"crossref","first-page":"752546","DOI":"10.3389\/fendo.2021.752546","volume":"12","author":"N Jiang","year":"2021","unstructured":"Jiang N, et al. NLRP3 inflammasome: A new target for prevention and control of osteoporosis?? Front Endocrinol (Lausanne). 2021;12:752546.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1189_CR8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0004563218759371","volume":"55","author":"JS Kenkre","year":"2018","unstructured":"Kenkre JS, Bassett J. The bone remodelling cycle. Ann Clin Biochem. 2018;55:308\u201327.","journal-title":"Ann Clin Biochem"},{"key":"1189_CR31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","volume":"23","author":"S Khosla","year":"2012","unstructured":"Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab. 2012;23:576\u201381.","journal-title":"Trends Endocrinol Metab"},{"key":"1189_CR41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5483\/BMBRep.2014.47.8.206","volume":"47","author":"JY Kim","year":"2014","unstructured":"Kim JY, Cheon YH, Yoon KH, Lee MS, Oh J. Parthenolide inhibits osteoclast differentiation and bone resorbing activity by down-regulation of NFATc1 induction and c-Fos stability, during RANKL-mediated osteoclastogenesis. BMB Rep. 2014;47:451\u20136.","journal-title":"BMB Rep"},{"key":"1189_CR29","doi-asserted-by":"crossref","unstructured":"Lee K, Seo I, Choi MH, Jeong D. (2018) Roles of Mitogen-Activated protein kinases in osteoclast biology. Int J Mol Sci 19.","DOI":"10.3390\/ijms19103004"},{"key":"1189_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00109-019-01839-0","volume":"98","author":"Q Li","year":"2020","unstructured":"Li Q, et al. ACT001 modulates the NF-kappaB\/MnSOD\/ROS axis by targeting IKKbeta to inhibit glioblastoma cell growth. J Mol Med (Berl). 2020;98:263\u201377.","journal-title":"J Mol Med (Berl)"},{"key":"1189_CR1","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2174\/0929867327666200330142432","volume":"28","author":"H Li","year":"2021","unstructured":"Li H, Xiao Z, Quarles LD, Li W. Osteoporosis: mechanism, molecular target and current status on drug development. Curr Med Chem. 2021;28:1489\u2013507.","journal-title":"Curr Med Chem"},{"key":"1189_CR39","doi-asserted-by":"crossref","first-page":"175091","DOI":"10.1016\/j.ejphar.2022.175091","volume":"928","author":"H Li","year":"2022","unstructured":"Li H, et al. Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome. Eur J Pharmacol. 2022;928:175091.","journal-title":"Eur J Pharmacol"},{"key":"1189_CR12","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bbrc.2020.03.177","volume":"526","author":"S Liang","year":"2020","unstructured":"Liang S, Nian Z, Shi K. Inhibition of RIPK1\/RIPK3 ameliorates osteoclastogenesis through regulating NLRP3-dependent NF-kappaB and MAPKs signaling pathways. Biochem Biophys Res Commun. 2020;526:1028\u201335.","journal-title":"Biochem Biophys Res Commun"},{"key":"1189_CR4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s11658-022-00371-3","volume":"27","author":"B Liang","year":"2022","unstructured":"Liang B, Burley G, Lin S, Shi YC. Osteoporosis pathogenesis and treatment: existing and emerging avenues. Cell Mol Biol Lett. 2022;27:72.","journal-title":"Cell Mol Biol Lett"},{"key":"1189_CR36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12979-023-00395-z","volume":"21","author":"R Liang","year":"2024","unstructured":"Liang R, et al. The role of NLRP3 inflammasome in aging and age-related diseases. Immun Ageing. 2024;21:14.","journal-title":"Immun Ageing"},{"key":"1189_CR10","doi-asserted-by":"crossref","first-page":"112539","DOI":"10.1016\/j.bbr.2020.112539","volume":"383","author":"Q Liu","year":"2020","unstructured":"Liu Q, et al. Anti-neuroinflammatory effects of dimethylaminomylide (DMAMCL, i.e., ACT001) are associated with attenuating the NLRP3 in Fl ammasome in MPTP-induced Parkinson disease in mice. Behav Brain Res. 2020;383:112539.","journal-title":"Behav Brain Res"},{"key":"1189_CR44","doi-asserted-by":"crossref","first-page":"108632","DOI":"10.1016\/j.intimp.2022.108632","volume":"107","author":"F Long","year":"2022","unstructured":"Long F, et al. Epoxymicheliolide inhibits osteoclastogenesis and resists OVX-induced osteoporosis by suppressing ERK1\/2 and NFATc1 signaling. Int Immunopharmacol. 2022;107:108632.","journal-title":"Int Immunopharmacol"},{"key":"1189_CR16","doi-asserted-by":"crossref","first-page":"114808","DOI":"10.1016\/j.biopha.2023.114808","volume":"163","author":"H Luo","year":"2023","unstructured":"Luo H, et al. ACT001 ameliorates ionizing radiation-induced lung injury by inhibiting NLRP3 inflammasome pathway. Biomed Pharmacother. 2023;163:114808.","journal-title":"Biomed Pharmacother"},{"key":"1189_CR30","doi-asserted-by":"crossref","unstructured":"Maeda K et al. (2022) Inflammation and bone metabolism in rheumatoid arthritis: molecular mechanisms of joint destruction and Pharmacological treatments. Int J Mol Sci 23.","DOI":"10.3390\/ijms23052871"},{"key":"1189_CR40","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrd.2018.149","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17:688.","journal-title":"Nat Rev Drug Discov"},{"key":"1189_CR28","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.2174\/0113892010273783231027073117","volume":"25","author":"R Muniyasamy","year":"2024","unstructured":"Muniyasamy R, Manjubala I. Insights into the mechanism of osteoporosis and the available treatment options. Curr Pharm Biotechnol. 2024;25:1538\u201351.","journal-title":"Curr Pharm Biotechnol"},{"key":"1189_CR42","doi-asserted-by":"crossref","unstructured":"Park JH, Kang YH, Hwang SC, Oh SH, Byun JH. (2020) Parthenolide has negative effects on in vitro enhanced osteogenic phenotypes by inflammatory cytokine TNF-alpha via inhibiting JNK signaling. Int J Mol Sci 21.","DOI":"10.3390\/ijms21155433"},{"key":"1189_CR38","doi-asserted-by":"crossref","first-page":"110954","DOI":"10.1016\/j.intimp.2023.110954","volume":"124","author":"S Qiao","year":"2023","unstructured":"Qiao S, Zhang X, Chen Z, Zhao Y, Tzeng CM. Alloferon-1 ameliorates Estrogen deficiency-induced osteoporosis through dampening the NLRP3\/caspase-1\/IL-1beta\/IL-18 signaling pathway. Int Immunopharmacol. 2023;124:110954.","journal-title":"Int Immunopharmacol"},{"key":"1189_CR25","first-page":"154","volume":"34","author":"A Rashki Kemmak","year":"2020","unstructured":"Rashki Kemmak A, et al. Economic burden of osteoporosis in the world: A systematic review. Med J Islam Repub Iran. 2020;34:154.","journal-title":"Med J Islam Repub Iran"},{"key":"1189_CR32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrd3669","volume":"11","author":"K Redlich","year":"2012","unstructured":"Redlich K, Smolen JS. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 2012;11:234\u201350.","journal-title":"Nat Rev Drug Discov"},{"key":"1189_CR3","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","volume":"399","author":"IR Reid","year":"2022","unstructured":"Reid IR, Billington EO. Drug therapy for osteoporosis in older adults. Lancet. 2022;399:1080\u201392.","journal-title":"Lancet"},{"key":"1189_CR24","doi-asserted-by":"crossref","first-page":"882241","DOI":"10.3389\/fendo.2022.882241","volume":"13","author":"Y Shen","year":"2022","unstructured":"Shen Y, et al. The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990\u20132019. Front Endocrinol (Lausanne). 2022;13:882241.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1189_CR9","doi-asserted-by":"crossref","first-page":"116353","DOI":"10.1016\/j.bone.2022.116353","volume":"159","author":"N Takegahara","year":"2022","unstructured":"Takegahara N, Kim H, Choi Y. RANKL biology. Bone. 2022;159:116353.","journal-title":"Bone"},{"key":"1189_CR13","doi-asserted-by":"crossref","first-page":"105967","DOI":"10.1016\/j.phrs.2021.105967","volume":"174","author":"H Tao","year":"2021","unstructured":"Tao H, et al. Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-kappaB activated pyroptosis pathways. Pharmacol Res. 2021;174:105967.","journal-title":"Pharmacol Res"},{"key":"1189_CR14","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.7150\/thno.41498","volume":"10","author":"L Tong","year":"2020","unstructured":"Tong L, et al. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 2020;10:5943\u201356.","journal-title":"Theranostics"},{"key":"1189_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","volume":"39","author":"N Udagawa","year":"2021","unstructured":"Udagawa N, et al. Osteoclast differentiation by RANKL and OPG signaling pathways. J Bone Min Metab. 2021;39:19\u201326.","journal-title":"J Bone Min Metab"},{"key":"1189_CR35","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","volume":"177","author":"Q Wang","year":"2020","unstructured":"Wang Q, et al. Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-kappaB pathway in mice. Br J Pharmacol. 2020;177:1806\u201321.","journal-title":"Br J Pharmacol"},{"key":"1189_CR45","doi-asserted-by":"crossref","first-page":"8757","DOI":"10.1021\/jm301064b","volume":"55","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, et al. Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. J Med Chem. 2012;55:8757\u201369.","journal-title":"J Med Chem"},{"key":"1189_CR20","doi-asserted-by":"crossref","first-page":"873054","DOI":"10.3389\/fimmu.2022.873054","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, et al. ACT001 inhibits TLR4 signaling by targeting Co-Receptor MD2 and attenuates neuropathic pain. Front Immunol. 2022;13:873054.","journal-title":"Front Immunol"},{"key":"1189_CR21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41467-025-55929-4","volume":"16","author":"QY Zhang","year":"2025","unstructured":"Zhang QY, et al. Regulation of enzymatic lipid peroxidation in osteoblasts protects against postmenopausal osteoporosis. Nat Commun. 2025;16:758.","journal-title":"Nat Commun"},{"key":"1189_CR6","doi-asserted-by":"crossref","unstructured":"Zhivodernikov IV, Kirichenko TV, Markina YV, Postnov AY, Markin AM. (2023) Molecular and cellular mechanisms of osteoporosis. Int J Mol Sci 24.","DOI":"10.3390\/ijms242115772"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01189-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01189-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01189-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T20:27:37Z","timestamp":1744057657000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01189-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01189-3","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed according to the institutional animal care guidelines established by the Institutional Animal Care and Use Committee of Hebei University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}